In cancer treatment, timely detection of cancer cell spread is crucial. In this process, the role of sentinel lymph nodes becomes increasingly important. Sentinel lymph nodes are considered the first lymph nodes around tumors that are most likely to be invaded by cancer cells. Regular testing can help doctors better understand the condition of the cancer and develop a suitable treatment plan.
Sentinel lymph node dissection (SLNB) is an important method to evaluate the spread of cancer.
Sentinel lymph nodes are usually the first lymph nodes to clear the obstruction. These lymph nodes are the first to receive lymph fluid from the tumor. Therefore, knowing whether these lymph nodes are invaded by cancer cells is very critical for determining the staging and prognosis of cancer. When a tumor's lymph nodes are positive for metastasis, it may indicate the spread of cancer cells to other locations.
The surgery is divided into several steps. First, doctors will inject a low-radioactive substance called filtered sulfur colloid to mark the lymph nodes. Scans will next be performed to identify stained lymph nodes, which can be radioactively traced to the nodes.
The success of this process is related to the formulation of subsequent treatment plans and the accuracy of tumor staging.
Clinically, sentinel lymphadenectomy can effectively reduce unnecessary lymph node dissection, thereby reducing the risk of lymphedema. This is particularly important for surgical operations on tumors such as breast cancer and malignant melanoma. In addition, this technology also provides a bridge to study tumor biology, helping the medical community gain a deeper understanding of the mechanism of cancer spread and its response to treatment.
Although sentinel lymphadenectomy has many advantages, it is not without challenges. Studies have shown that if a sentinel lymph node test is negative, cancer cells may still be present, causing a false negative result. At the same time, there is still controversy about whether complete lymphadenectomy improves survival chances in some patients.
The concept of sentinel lymph nodes was first proposed by Gould in 1960 and was widely used clinically in the following decades, especially in the treatment of breast cancer and cutaneous melanoma.
With the advancement of medical technology, sentinel lymph node dissection has become an indispensable part of cancer treatment.
With the development of science and technology, the detection methods of sentinel lymph nodes are also constantly improving. The introduction of new technologies will help reduce false negative rates and improve the accuracy of early detection of cancer.
Here, we can’t help but ask, how do you think future medical technology will further change the way cancer is diagnosed and treated?